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Chapter 1 Introduction 
 
1.1 Background 
 
Myocardial infarction (MI) is caused by the occlusion of the coronary 
artery mainly due to atherosclerotic plaque rupture. Despite important 
advances in drug and device therapy, MI remains a leading cause of death 
and morbidity worldwide, especially because of heart failure and 
ventricular arrhythmia (Savard et al. 1997; Bahit et al. 2018). Acute 
ischemic injury leads to the activation of neurohormones and cytokines, 
subsequent myocardial remodeling, a further decline in cardiac function, 
and finally overt heart failure (Schober and Knollmann 2007; Zhang et al. 
2010). During this pathophysiological progress, malignant arrhythmias 
such as ventricular tachyarrhythmias, associated with imbalance of the 
autonomic nervous system (ANS), are a major cause of death (Kalla et al. 
2016; Shen et al. 2014).  
β-adrenergic receptor blocker (β-blocker) has been established as a 
first-line medication for heart failure patients to reduce mortality. Long-
term treatment with β-blockers can lessen the symptoms of heart failure 
and improve the patient’s clinical status (Yancy et al. 2013). 
There are increasing evidences that exercise training is an effective 
non-pharmacological treatment for cardiovascular diseases with a 
beneficial effect on disease progression and survival (Anderson et al. 2016; 
La Rovere et al. 2002). The American Heart Association guidelines for 
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heart failure published in 2005 recommend exercise training for stable 
outpatients with heart failure and a reduced left ventricular ejection fraction 
(LVEF) (Hunt et al. 2005). In post-MI patients, multiple previous studies 
reported that exercise could beneficially reduce post-MI remodeling and 
improve cardiac function (French et al. 2008; Guizoni et al. 2016; Kemi et 
al. 2007; Lu et al. 2002). Exercise training also causes a reverse remodeling 
of cardiac autonomic regulation such that parasympathetic activity is 
enhanced while sympathetic activity is reduced, resulting to improvement 
of heart rate variability (HRV) (Malfatto et al. 1996) and suppression of 
ventricular tachyarrhythmia (Billman 2009; Bonilla et al. 2012; Kukielka et 
al. 2011). Recently, intensive exercise training has been reported to have 
greater improvement than low intensive or moderate intensive training 
(Howden et al. 2018; Jaureguizar et al. 2016). 
Cardiac rehabilitation (CR) programs are recognized as integral to 
comprehensive care of cardiac patients, with exercise therapy consistently 
identified as a central element, and have been given a Class I 
recommendation from the American Heart Association, the American 
College of Cardiology, and the European Society of Cardiology (Anderson 
et al. 2016). For acute MI patients, CR is known not only to improve 
cardiopulmonary function and the quality of life, but also allows for the 
more efficient management of risk factors (Zhang et al. 2018; Kim et al. 
2012). During the process of CR, cardiopulmonary exercise testing (CPX) 
is the most useful clinical tool for evaluating the severity of disease and the 
limitations of physical activities in cardiac patients, which becomes the 
standard in making exercise prescription (Figure 1). Oxygen consumption 
at peak exercise (peak VO2) reflects maximal cardiac output during 
exercise and is accordingly considered the standard for evaluating exercise 
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tolerance and cardiopulmonary function (Balady et al. 2010). Furthermore, 
it has also be accepted as the main indicator of predicting prognosis in 
cardiac patients and a gold standard in selecting patients for cardiac 
transplantation (Balady et al. 2010). Under the guidance of CPX, cardiac 
rehabilitation not only reduces the mortality rate of MI, but also lowers the 
recurrence rate of acute MI. 
Although many cardiac disease patients may have benefited from the 
above-mentioned effects through cardiac rehabilitation, the actual cases of 
request for cardiac rehabilitation are not very common (Kim et al. 2012). 
At present, cardiac rehabilitation is still the short board in the overall 
treatment of coronary heart disease. The development of community-based 
cardiac rehabilitation in acute MI patients is still unsatisfactory, <25% of 
outpatients have been reported to enroll in CR, with <10% in elderly 
patients, within this small number of patients participating in CR, 30% to 
40% of patients discontinued CR after 6 months, with up to 50% dropping 
out after 1 year (Wolkanin-Bartnik et al. 2011). While the need and the 
effects of cardiac rehabilitation are so well known as not to produce any 
disagreement, it is true that not only the patients who request cardiac 
rehabilitation but also the medical team who are involved in the cardiac 
rehabilitation have concerns regarding cardiovascular-related complications 
that may occur during monitoring exercises (Kim et al. 2012). Patients with 
heart failure were advised to avoid physical exertion at last century. There 
are controversial results about the effects of exercise, especially the high 
intensive exercise. Both experimental and clinical athlete studies 
demonstrated that intensive exercise was associated with enhanced 
myocardium fibrosis and dyssynchrony leading to electrical instability and 
arrhythmia (Guasch et al. 2013; Karjalainen et al. 1998). The risk of AMI 
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is also increased with approximately 5–10% of all infarcts being associated 
with intense physical activity (Thompson et al. 2003).  
On the other hand, it remains to be fully elucidated what are the 
underlying mechanisms. Various researches attributed to different opinions 
(La Rovere et al. 2002; Kemi et al. 2007; Guizoni et al. 2016). 
Furthermore, it keeps unclear how does exercise training alter the 
cellular/molecular abnormalities to protect against malignant arrhythmias 
after MI and what are the underlying mechanisms. 
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Figure 1. Cardiac rehabilitation (CR) and cardiopulmonary exercise 
testing (CPX) 
Cardiac rehabilitation (CR) programs are recognized as integral to 
comprehensive care of cardiac patients and have been given a Class I 
recommendation, with exercise therapy consistently identified as a central 
element. During the process of CR, cardiopulmonary exercise testing 
(CPX) is the most useful clinical tool for evaluating the severity of disease 
and the limitations of physical activities in cardiac patients, which becomes 
the standard in making exercise prescription. 
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1.2 Objective 
 
In this study, we aim to explore the effects and mechanisms by 
intensive exercise training in post-MI mice, especially anti-arrhythmic 
potential, via comparing the effects of exercise versus an established first-
line medicine β-blocker treatment. 
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Chapter 2 Methods 
 
 
2.1 Ethics statement 
 
All animal experimental procedures in this study were approved by the 
Institutional Animal Experiment Committee of the University of Tsukuba. 
Experiments were conducted in accordance with the Guide for the Care and 
Use of Laboratory Animals published by the US National Institutes of 
Health and the Fundamental Guideline for Proper Conduct of Animal 
Experiment and Related Activities in Academic Research Institutions under 
the jurisdiction of the Ministry of Education, Culture, Sports, Science and 
Technology of Japan. 
 
2.2 Mouse model and study protocol 
 
Total 96 wild-type male mice (C57Bl/6J) purchased from CLEA Japan, 
Inc. (Tokyo, Japan) were used in this study. After adapting the environment 
for 2-3 weeks and reaching 11-12 weeks old, MI operation was performed 
in 75 mice as described previously (Stujanna et al. 2017). Mice were 
anesthetized with ketamine and xylazine, followed by tracheal intubation 
and artificial ventilation (MiniVent 845; Harvard Apparatus, Holliston, 
MA, USA). Next, a thoracotomy was performed to expose the heart, and 
MI was induced by the permanent ligation of the left anterior descending 
coronary artery (LAD) with 7-0 polypropylene suture passed about 2 mm 
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from the inferior margin of the left atrial auricle. MI was confirmed by 
visual observation of myocardial color change and the following 
echocardiographic assessment at the 7th day after MI operation. 21 mice 
were subjected to a similar procedure without ligation of the LAD as the 
sham group. After closure of the thorax and recovery of spontaneous 
breathing, the mice were extubated and placed in a new box on the warm 
pad for recovery. In the first week after MI operation, 20 mice died 
(probably due to heart failure and/or arrhythmia). At the 7th day after 
MI/Sham operation 76 mice were performed echocardiographic assessment 
to confirm MI area and obtain initial parameters. Then, 55 MI mice were 
randomly divided into 3 groups: sedentary group (20 mice; MI-Sed), 
exercise training group (17 mice; MI-Ex) and β-blocker treatment group 
(18 mice; MI-βb). The study protocol is shown in Figure 2. 
 
 
 
 
 9 
 
 
Figure 2. Study protocol 
Wild-type male mice (C57Bl/6J) underwent MI/sham operation at the age 
of 11-12 weeks old. At the 7th day after operation mice were performed 
echocardiographic assessment. Then, mice were randomly divided into 4 
groups: sham group (Sham), sedentary group of MI mice (MI-Sed), 
exercise training group (MI-Ex) and β-blocker treatment group (MI-βb). 
There was neither treatment nor exercise training in Sham and MI-Sed, 
while MI-Ex/MI-βb started treadmill training/Bisoprolol treatment from the 
8th day after MI operation. After 6 weeks, mice were received assessments 
of echocardiography, exercise capacity and cardiopulmonary function. 
Telemetry devices were implanted into the body of mice to abtain data of 
electrocardiography (ECG) and heart rate variability (HRV) analysis. Then, 
mice were sacraficed and left ventricular (LV) tissues were excised for 
laboratory assessments.   
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2.3 Exercise training and β-blocker treatment protocol 
 
Mice in MI-Ex started treadmill training from the 8th day after MI 
operation for 6 weeks. Training was performed with a ten-lane treadmill at 
0% slope (MK-680, Muromachi Kikai Co., Ltd., Tokyo, Japan). The 
training intensity was determined as the maximum speed and endurance 
time when the animals were not able to run further. In the first week the 
training intensity started at 6 meters per minute (m/min) for 30 minutes and 
increased progressively in the following days, until 18 m/min for 
45minutes/day when mice showed exhaustion. Then the maximal intensity 
(18m/min × 45minutes) was maintained for 5 weeks and consequent 5 days 
every week.  
MI-βb mice were treated with Bisoprolol Hemifumarate (Tokyo 
Chemical Industry Co., Ltd., Tokyo, Japan) via water solution from the 8th 
day after MI operation for 6 weeks. The dosage was 1 mg/kg/day based on 
the previous report (Yamada et al. 2014). Firstly, we evaluated water intake 
per day of each mouse after operation (approximately 4 ml/day) and then 
the concentration was determined (0.0075 mg/mL). 
 
2.4 Echocardiography 
 
We performed echocardiographic assessments 3 times during the 
experiment (on 7th day after MI/sham operation, after 3 weeks of 
intervention and after 6 weeks of intervention). In brief, mice were 
anesthetized by isoflurane and echocardiographic images were obtained at 
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the papillary muscle level using a 40 MHz transducer connected to Doppler 
echocardiographic system (Vevo 2100; Visual Sonics, Toronto, Canada). 
Both the parasternal long-axis view and short-axis view were acquired. Left 
ventricular end-diastolic diameter (LVDd), LV end-systolic diameter 
(LVDs), LV ejection fraction (LVEF), and fractional shortening (FS) were 
measured or calculated in short-axis two-dimensional M-mode images (Tan 
et al. 2003). LVEF was calculated by the Teichholz method. FS was 
calculated as [(LVDd–LVDs)/LVDd] × 100%.  
 
2.5 Assessment of cardiopulmonary function and exercise capacity  
 
A metabolic running wheel chamber connected with a Mass 
Spectrometer for Respiratory Analysis (ARCO 2000; ARCO system Inc., 
Chiba, Japan) was used to assess exercise capacity and cardiopulmonary 
function. After 6 weeks of different interventions, 5-6 animals in each 
group were randomly chosen and weighed before the examination. Single 
mouse was put inside the sealed running wheel, forced to run at gradually 
increased speed, and maintained in the last velocity until exhaustion. 
Oxygen consumption at peak exercise (peak VO2, Nml/min/kg) was 
determined and normalized by body weight in kilograms. Exercise capacity 
and cardiopulmonary function was accepted as peak VO2 (Nml/min/kg) 
(Iwase et al. 2004) (Figure 3). 
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Figure 3. Assessment of cardiopulmonary function and exercise 
capacity  
Single mouse was weighted and put inside the sealed running wheel 
chamber, forced to run at gradually increased speed, and maintained in the 
maximal velocity to keep running. The respiratory analysis was performed 
through the Mass Spectrometer connected with the running wheel 
chambers. Peak VO2 (Nml/min/kg) was determined by the ARCO system 
software. 
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2.6 Electrocardiography telemetry recording and heart rate variability 
(HRV) analysis 
 
Continuous 24 hours electrocardiography (ECG) recordings were 
obtained from implanted telemetry devices (Figure 4). After 6 weeks of 
intervention, randomly-selected 5-6 animals in each group underwent 
telemetry implantation. Mice were anesthetized with a mixture of ketamine 
and xylazine, and the tele-transmitters (ETA-F20, Data Sciences 
International DSI, USA) were subcutaneously implanted in the midline of 
their back (less invasive than intraperitoneal implantation, thus ensuring a 
higher survival rate in post-MI mice). After implantation, each mouse was 
housed in a single cage and given enough recovery time of several days 
before starting the measurement. An analog signal from the telemetric 
receiver was applied to ECG and ANS modulations. Data were collected 
and analyzed off-line by a commercially-available software (Dataquest 
A.R.T. Data Sciences International DSI). Premature ventricular 
contractions (PVC) and ventricular tachycardias (VT: more than 3 PVC 
beats in succession) were pick out and counted from ECG recordings. Heart 
rate variability (HRV) analysis is generally used to index ANS function. 
Mean R–R intervals (in ms) and standard deviation of R-R intervals 
(SDNN) in time-domain analysis are considered to reflect total autonomic 
variability (Shaffer and Ginsberg 2017). In frequency-domain analysis, the 
high frequency power (HF) band reflects parasympathetic activity, while 
the low frequency power (LF) band reflects the combined function of both 
sympathetic and parasympathetic activity. A high LF/HF (the ratio of low 
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frequency power to high frequency power) indicates sympathetic 
dominance (Thireau et al. 2008). 
 
 
 
 
Figure 4. Telemetry implantation and electrocardiography recording 
A tele-transmitter (ETA-F20, Data Sciences International DSI, USA) was 
implanted subcutaneously in the mouse's back, which sent radiofrequency 
signals to a receiver located below the mouse cage. A data exchange matrix 
converts the analog signal into a digital signal before storage in the 
microcomputer. Data were collected and analyzed off-line by Dataquest 
A.R.T. software. 
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2.7 Autonomic tone assessment 
 
Autonomic tone components (reflecting parasympathetic and 
sympathetic tone) were assessed by mean of heart rate changes to 
sequential pharmacological blockade as described previously (Guasch et al. 
2013). Propranolol is widely used to evaluate the inhibition of the 
sympathetic system, while atropine administration is used to evaluate the 
inhibition of parasympathetic nervous system (Garabedian et al. 2017). To 
estimate parasympathetic tone, propranolol (2 mg/kg) was administrated 
intraperitoneally; 15 to 20 minutes later, parasympathetic effects were 
blocked with atropine (1 mg/kg). The parasympathetic tone index was 
defined according to the difference between HR after propranolol alone 
versus propranolol + atropine. Sympathetic tone index was the heart rate 
difference between atropine alone and atropine + propranolol. 
 
2.8 Histology and tissue analysis 
 
After the 6 week-intervention, the hearts, lungs, and sartorius muscles 
were excised and weighed at postmortem. The LVs at the level of the 
papillary muscle were fixed with 4% paraformaldehyde, embedded in 
paraffin, sectioned into 4-μm thick slices, and stained with Masson’s 
trichrome. Cross-section images of the LV were obtained by a digital 
microscope (Biozero BZ-X700; Keyence, Osaka, Japan), and MI area was 
calculated by dividing the collagen depositing area to the total area. In non-
infarcted area, the fibrosis area was calculated by image analyzing software 
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(ImageJ analysis software ver.1.45; NIH; Bethesda, MD, USA). The 
anatomical ratios of tissue weights to body weight (BW) were calculated, 
including the ratios of heart weight to BW, LV weight to BW, right 
ventricular weight to BW, lung weight to BW, left atrial + right atrial 
weight to BW, and the sartorius muscle (on the femur) weight to BW. 
 
2.9 Real-time PCR 
 
We performed real-time PCR to assess gene expression levels in the 
LVs, as described previously (Stujanna et al. 2017; Xu et al. 2012). In 
brief, total RNA was extracted from LV tissues using the RNeasy Fibrous 
Tissue Mini Kit (Qiagen, Hilden, Germany). A 1 µg of RNA was then 
reverse transcribed to cDNA with a High-Capacity cDNA RT Kit (Thermo 
Fisher Scientific, Inc., Waltham, MA, USA). The mRNA expression levels 
of the target genes were analyzed by an ABI Prism 7500 sequence 
detection system (Thermo Fisher Scientific) with gene-specific primers and 
probe sets (Integrated DNA Technologies, Coralville, IA, USA). The PCR 
mixture (10 μl total volume) consisted of the template, primer, and probe 
for each gene (250 nM), and the PrimeTime Gene Expression Master Mix 
(Integrated DNA Technologies, Skokie, IL, USA). PCR amplification was 
performed as follows: 1 cycle at 95°C for 10 min, and 40 cycles at 94°C for 
15 s and 60°C for 1 min. The primers and probes used in the study were as 
follows: MHC-α(M00440359-a1), MHC-β (M01319005-g1) (Thermo 
Fisher Scientific); Nppb (BNP: brain natriuretic peptide) 
(Mm.PT.58.8584045.g), β1-AR (β1 adrenergic receptor; 
Mm.PT.58.41132658.g), Grk5 (Mm.PT. 58.11422186), β2-AR (β2 
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adrenergic receptor; Mm.PT.58.29310038.g), Chrm2 
(Mm.PT.58.42964182.g), Col1a1 (Mm.PT.58.756.2513), Col3a1 
(Mm.PT.58.13848686), TGF-β1 (Rn01475964), Atp2a2 (SERCA2a: 
sarcoplasmic reticulum calcium ATPase); Mm.PT.58.5303089), PLN 
(phospholamban; Mm.PT.58.43778023), and RyR2 (ryanodine receptor 
type 2; Mm.PT.58.45974879) (Integrated DNA Technologies). For 
analyzing microRNAs (miRNA), 500 µg of RNA was reverse transcribed 
to cDNA with a miRNA primer using the miRNeasy Mini Kit (Qiagen). 
The miRNA primer assays used were miR-1 (RT: 002064, PN4427975) 
and miR-133a (TM: 000458, PN4427975). The PCR mixture was made 
and amplified as described above. The quantitative values of target mRNA 
and miRNA were normalized to expression of 18S rRNA (4319413E; 
Thermo Fisher Scientific). Data were obtained from 3 independent 
measurements (n=8/group) performed in duplicate. 
 
2.10  Western blotting analysis 
 
We evaluated protein expression in the LVs by Western blotting, as 
described previously (Stujanna et al. 2017; Xu et al. 2012). In brief, 
isolated LVs were homogenized in PRO-PREP protein extraction solution 
(iNtRON Biotechnology, Inc., Kyungki-Do, Korea), and the supernatants 
were collected. A 10 μg of proteins were transferred by semidry 
electroblotting from gels (Bio-Rad Laboratory, Hercules, CA, USA) to 
polyvinylidene difluoride membranes. The blots were then blocked with 
the primary antibodies as follows: phospho-RyR2 (Ser 2814) (A010-31; 
Badrilla, Leeds, UK), phospho-RyR2 (Ser 2808) (A010-30, Badrilla), 
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RyR2 (PA5-36121; Thermo Fisher Scientific), SERCA2a (2A7-A1; 
Thermo Fisher Scientific), phospho-Phospholamban (p-PLN) (S16+T17; 
ab62170; Abcam, Cambridge, UK), total Phospholamban (PLN) (ab2865; 
Abcam), phospho-PKA (T197; ab75991; Abcam), PKA (ab187515; 
Abcam), phospho-CaMKII (T286) (ab32678; Abcam), Oxidized-CaMKII 
(Met281/282) (EMD Millipore, Darmstadt, Germany), total CaMKII 
(ab103840; Abcam), protein phosphatase 2A (PP2A)-B56-α (F-10; sc-
271151; Santa Cruz, Dallas, TX, USA), phospho-Troponin-I (p-TNI) 
(Ser23/24) (#4004; Cell Signaling Technology, Danvers, MA, USA), total 
Troponin-I (TNI) (#4002; Cell Signaling Technology), PP1 (E-9; sc-7482; 
Santa Cruz), and β-actin (4967s; Cell Signaling Technology). The blots 
were incubated with an appropriate horseradish peroxidase-conjugated goat 
anti-rabbit IgG (ab6721; Abcam) or horseradish peroxidase-conjugated 
rabbit anti-mouse IgG (ab97046; Abcam) secondary antibody. 
Immunoreactions were visualized with an enhanced chemiluminescence 
method (ECL Prime Western Blotting Detection; GE Healthcare, 
Southeast, UK). Densitometric analysis was performed on scanned 
immunoblot images (ImageJ analysis software ver.1.45; NIH; Bethesda, 
MD, USA). Data were obtained from 3 independent measurements 
(n=6/group). 
 
2.11  Statistical Analysis 
 
All data are expressed as mean ± standard error of the mean (SEM). To 
compare the values between groups, continuous values were analyzed by 
one-way ANOVA followed by post hoc-testing with Bonferroni's test. 
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Significance was accepted when P<0.05. Statistical analysis was performed 
using IBM SPSS version 21.0 software (IBM Co. Ltd., Armonk, NY, 
USA). 
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Chapter 3 Results 
 
 
3.1 Exercise training does not affect survival rate, MI size, and fibrosis 
in non-infarcted area, but enhances exercise capacity and 
cardiopulmonary function.  
 
During the 6 weeks of training or treatment, 3 mice in MI-Sed (3/20: 
15.0%) and 1 mouse in MI-Ex (1/17: 6.8%) died, while no mice died in 
Sham (0/21: 0.0%) and MI-βb (0/18: 0.0%) groups. There was no 
significant difference in the survival rate between the MI groups. As 
ventricular rupture was not observed in the 4 dead mice, we assumed death 
from cardiac arrhythmia or heart failure.  
Masson’s trichrome (MT) staining images of the LVs showed no 
differences in the infarct area between the three MI groups (Fig. 5A, B). 
We assessed the exercise capacity and cardiopulmonary function of mice 
via a metabolic running wheel chamber. Peak VO2 was decreased in MI-
Sed and MI-βb compared with Sham and was restored in MI-Ex (Fig. 5C).    
In the non-infarcted area, real-time PCR for the fibrosis markers 
showed no significant differences in the gene expression levels of Col1a1, 
Col3a1 and TGF-β1 (Fig. 6A, B and C). MT staining images of the LVs 
showed there was no significant difference in the fibrosis area (Fig. 6D, E).  
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Figure 5. Cross-sectional findings of the left ventricles at the papillary 
muscle level and cardiopulmonary function.  
A: In Masson’s trichrome staining images of the left ventricle (LV), the 
blue thinning region indicates the infarct area. B: There was no difference 
in the infarct area between the 3 MI groups (MI-Sed group: 40.1%±1.8% 
vs. MI-Ex group: 39.4%±1.4% vs. MI-βb: 39.3%±2.7 %; n=8/group). 
*P<0.05, vs. Sham. C: Oxygen consumption at peak exercise (Peak-VO2) 
was decreased in MI-Sed and MI-βb groups, and was restored in MI-Ex, 
compared with Sham (Sham, 97.2 ± 2.3; MI-Sed, 83.8 ± 3.7; MI-Ex, 95.7 ± 
2.4; MI-βb, 86.3 ± 1.0, Nml/min/kg) (n=5/group in Sham, MI-Sed, and MI-
βb; n=6 in MI-Ex). *P<0.05, vs. Sham; #P<0.05, vs MI-Sed. 
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Figure 6. The fibrosis in non-infarcted area of the left ventricles.  
A, B and C: There were no significant differences in the gene expression 
levels of Col1a1, Col3a1, and TGF-β1 between all groups. D: In Masson’s 
trichrome staining images of non-infarcted area (at 20 × magnification), the 
regions stained blue indicate collagen deposition. E: There was no obvious 
difference in the collagen deposition area between groups in non-infarcted 
area (Sham, 2.86 ± 0.21 %; MI-Sed, 4.53 ± 0.40 %; MI-Ex, 3.75 ± 0.67 %; 
MI-βb, 3.62± 0.40 %; n=6/group). 
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3.2 Exercise training has no apparent effect on cardiac contractility or 
hypertrophy  
 
3.2.1 Echocardiographic analysis 
 
Before intervention, echocardiography at the 7th day after MI/sham 
operation demonstrated that LV was enlarged, and the LV systolic function 
was reduced in all MI groups compared with Sham, but there was no 
obvious difference between 3 MI groups (Figure 7). After 3-week 
intervention, LVDd and LVDs in all MI mice were progressively increased; 
however, there were no significant differences between MI groups. LVEF 
(%) and FS (%) were also not significantly different between MI groups. 
After 6-week intervention, the results showed the similar tendency as 3 
weeks after MI. LVEF (%) was slightly improved by exercise and β-
blocker treatment, while there were no significant differences in MI groups 
(Table 1). 
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Figure 7. Representative images of echocardiographic analysis 
The representative two-dimensional M-mode images of the left ventricular 
short-axis view show thinning of the anteroseptal wall, enlargement of the 
left ventricle, and reduced left ventricular systolic function in all MI groups 
compared with Sham. 
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Table 1. Echocardiographic analysis.  
Variable 
 
Sham MI-Sed MI-Ex MI-βb 
LVDd (mm) pre 3.36±0.13 4.54±0.26* 4.62±0.16* 4.81±0.12* 
 mid  4.83±0.18 4.77±0.16 4.94±0.20 
 post 3.49±0.08 5.01±0.10* 4.82±0.17* 5.00±0.13* 
LVD s(mm) pre 2.41±0.16 3.95±0.29* 4.02±0.16* 4.17±0.14* 
 mid  4.16±0.20 4.14±0.17 4.27±0.18 
 post 2.45±0.15 4.18±0.17* 4.13±0.18* 4.25±0.12* 
LVEF (%) pre 56.12±3.25 29.23±2.91* 28.06±1.32* 28.62±1.85* 
 mid  29.78±2.40 28.45±2.16 29.20±1.68 
 post 57.62±3.10 31.03±2.85* 30.91±2.09* 31.49±0.99* 
FS (%) pre 28.67±2.06 13.67±1.42* 13.05±0.64* 13.41±1.07* 
 mid  14.03±1.21 13.33±1.11 13.73±0.85 
 post 28.65±1.64 14.79±1.40* 14.61±1.08* 15.16±0.57* 
 
Data are presented as mean ± standard error of the mean (SEM).  
pre, at the 7th day after MI/sham operation; 
mid, after 3 weeks of intervention; 
post, after 6 weeks of intervention.  
*P<0.05, vs. Sham. 
 
  
 26 
 
3.2.2 Anatomical data 
 
Anatomical data indicated that the ratios of LV weight to BW, right 
ventricular weight to BW, and lung weight to BW were significantly 
increased in all MI groups compared with Sham (Table 2). These values 
also showed a trend towards a slight increase after 6 weeks. However, only 
the ratio of the sartorius muscle weight to BW was significantly increased 
in MI-Ex compared with the others. These data suggest that exercise 
training strengthened the skeletal muscles but had no apparent effect on 
cardiac hypertrophy. 
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Table 2. Anatomical data 
Variable Sham MI-Sed MI-Ex MI-βb 
BW (g) 27.99±0.54 29.36±0.32 28.14±0.46 29.18±0.44 
HW/BW (%) 4.01±0.06 4.78±0.12* 5.21±0.15* 4.95±0.13* 
LVW/BW (%) 2.98±0.05 3.62±0.08* 3.85±0.11* 3.71±0.10* 
RVW/BW (%) 0.78±0.03 0.86±0.03 1.01±0.05 0.94±0.03 
LW/BW (%) 4.58±0.09 4.63±0.09 5.01±0.11 4.64±0.06 
AW/BW (%) 0.24±0.01 0.28±0.01 0.34±0.02 0.31±0.02 
SMW/BW (%) 8.16±0.19 7.30±0.26 9.10±0.28# 7.74±0.32 
 
Data are presented as mean ± SEM.  
BW, body weight; HW/BW (%), the ratio of whole heart weight to BW; 
LVW/BW (%), the ratio of left ventricular weight to BW; RVW/BW (%), 
the ratio of right ventricular weight to BW; LW/BW (%), the ratio of lung 
weight to BW; AW/BW (%), the ratio of left atrial + right atrial weight to 
BW; SMW/BW (%), the ratio of sartorius muscle (on the femur) weight to 
BW.  
*P<0.05, vs. Sham; #P<0.05, vs. MI-Sed (n=9/group). 
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3.3 Exercise regulates the autonomic imbalance and reduces the 
occurrence of arrhythmias  
 
3.3.1 The heart rate variability (HRV) analysis  
 
HRV analysis in the time and frequency domains was used to evaluate 
cardiac autonomic function in conscious mice (Thireau et al. 2008). Mean 
heart rate (HR) was significantly lower in the MI-βb group compared with 
the other groups (Sham, 550 ± 17 beats per min (bpm); MI-Sed, 563 ± 51 
bpm; MI-Ex, 554 ± 29 bpm; MI-βb, 476 ± 35 bpm) (Fig. 8A). In time-
domain parameters, MI-βb mice demonstrated prolonged mean R–R 
intervals and standard deviation of R–R intervals (SDNN) (Fig. 8B, C). 
Frequency domain analysis indicated that the high frequency power (HF) 
and the low frequency power (LF) showed no significant differences. 
While LF/HF, an index of sympathetic tone activity, was decreased in MI-
Ex and MI-βb compared with MI-Sed (Fig. 8D, E and F). 
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Figure 8. HRV analysis in the time and frequency domains 
A: Mean heart rate (HR) was significantly lower in MI-βb compared with 
the other groups. B, C: In time-domain parameters of HRV analysis, MI-
βb demonstrated prolonged mean R–R intervals (Sham, 114.1 ± 4.2 ms; 
MI-Sed, 112.2 ± 3.8 ms; MI-Ex, 115.4 ± 4.1 ms; MI-βb, 132.9 ± 3.6 ms) 
and standard deviation of R–R intervals (SDNN; Sham, 32.6 ± 2.0 ms; 
MI-Sed, 28.0 ± 3.0 ms; MI-Ex, 29.8 ± 5.4 ms; MI-βb, 46.7 ± 5.2 ms). D: 
In frequency domain analysis, HF showes a trend towards a decrease in 
MI groups (Sham, 0.068 ± 0.0059 s²/Hz; MI-Sed, 0.057 ± 0.0096 s²/Hz; 
MI-Ex, 0.057 ± 0.0021 s²/Hz; MI-βb, 0.050 ± 0.0035 s²/Hz); E: LF had no 
obvious difference (Sham, 0.19 ± 0.07 s²/Hz; MI-Sed, 0.16 ± 0.01 s²/Hz; 
MI-Ex, 0.15 ± 0.002 s²/Hz; MI-βb, 0.17 ± 0.01 s²/Hz). F: The LF/HF ratio, 
was significantly increased in MI-Sed compared with Sham, and it was 
restored in MI-Ex and MI-βb. (Sham, 2.60 ± 0.90 s²/Hz; MI-Sed, 3.92 ± 
0.38 s²/Hz; MI-Ex, 2.83 ± 0.14 s²/Hz; MI-βb, 3.68 ± 0.27 s²/Hz), 
(n=4/group). *P<0.05, vs. Sham; #P<0.05, vs. MI-Sed.  
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3.3.2 Autonomic tone assessment 
 
At baseline ECG there was no obvious difference in mean HR of Sham, 
MI-Sed and MI-Ex groups, except MI-βb. After injection of propranolol 
and following atropine (Figure 9), every group indicated an initial 
decrease and subsequent increase in HR. The HR difference between 
injection of propranolol and propranolol + atropine is considered as the 
parasympathetic tone index.  Between them, MI-Ex displayed a 
significant difference, compared with others, which indicated an enhanced 
parasympathetic tone. But as to the sympathetic tone, the heart rates didn’t 
show apparent change after initial injection of atropine and subsequent 
propranolol + atropine.  
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Figure 9. Autonomic tone assessment  
(A)After injection of propranolol and following atropine, every group 
indicated an initial decrease [2] and subsequent increase [3] in HR. 
Between them, MI-Ex displayed a significant difference, compared with 
others (B) (Sham, 49 ± 15; MI-Sed, 42 ± 7; MI-Ex, 77 ± 36; MI-βb, 12 ± 
17, bpm), which indicated an enhanced parasympathetic tone. *P<0.05, vs. 
Sham; #P<0.05, vs. MI-Sed (n=5/group). 
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3.3.3 The occurrence of spontaneous arrhythmias 
 
We calculated the occurrence of spontaneous ventricular arrhythmic 
events including PVCs and VTs (Fig. 10A to D) in continuous ECG 
recordings. Mice in MI-Sed showed an increased incidence of PVCs 
compared with Sham, while exercise training and β-blocker treatment 
effectively reduced the occurrence (Fig. 10E). Notably, VTs were 
frequently observed in 3 of 6 mice (50%) in MI-Sed and the longest 
duration of VT was 22 seconds in a MI mouse, while 1 of 6 mice (17%) in 
MI-Ex, and no VT was observed in Sham or MI-βb (Fig. 10F). These data 
suggest that chronic exercise training can reduce the episodes of 
spontaneous ventricular arrhythmias, similarly to β-blocker treatment. 
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Figure 10. Representative images of the spontaneous ventricular 
arrhythmic events. PVC, premature ventricular contractions (indicated by 
the arrow); VT, ventricular tachycardias (indicated by the star).  
A: in Sham; B: in MI-Sed,; C: in MI-Ex; D: in MI-βb. E: Mice in MI-Sed 
showed an increased incidence of PVCs compared with Sham, while 
exercise training and β-blocker treatment effectively reduced the 
occurrence (Sham, 148 ± 143 counts/12 h; MI-Sed, 739 ± 377 counts/12 h; 
MI-Ex, 109 ± 44 counts/12 h; MI-βb, 172± 102 counts/12 h, n=6/group). F: 
VTs were frequently observed in 3 of 6 mice (50%) in MI-Sed and 1 of 6 
mice (17%) in MI-Ex. The longest duration of VT was 22 seconds in a MI-
Sed mouse. However, no VT was observed in Sham and MI-βb 
(n=6/group). *P<0.05, vs. Sham; #P<0.05, vs. MI-Sed. 
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3.4 Exercise influences calcium handling-related molecules  
 
3.4.1 Gene expressions of mRNAs  
 
Next, we assessed the expression of relevant genes in LV tissues. The 
expression of Nppb, which encodes BNP, was significantly higher in MI-
Sed versus Sham, but significantly lower in MI-Ex versus MI-Sed (Fig. 
11A). The ratio of MHC α/β showed no obvious change (Fig. 11B). The 
expression level of β1-AR was slightly decreased, and the expression of 
Grk5 was slightly increased in MI-Sed compared to Sham. However, we 
couldn’t find the significances between groups (Fig. 11C, D). The 
expressions of Chrm2 and β2-AR also showed no apparent changes (Fig. 
11E, F). 
The calcium handling pathway is highly involved in the incidence of 
cardiac arrhythmias and determines the force of myocardium contraction. 
RyR2 releases calcium from (SR) to the cytoplasm, while SERCA2a and 
PLN, an inhibitor of SERCA2a, coordinately mediate calcium reuptake into 
the SR (Lanner et al. 2010). Therefore, we investigated the changes in 
expressions of calcium handling related genes. The mRNA expressions of 
RyR2 and PLN were comparable in all groups, while the mRNA 
expression of Atp2a2 (SERCA2a) was significantly decreased in MI-Sed 
compared with Sham, and it was significantly increased in MI-Ex and MI-
βb groups (Fig. 11G, H and I). 
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Figure 11. Gene expression levels analyzed by real-time PCR 
A: The mRNA expression of Nppb (BNP) was significantly higher in MI-
Sed than Sham and was significantly lower in MI-Ex and MI-βb than MI-
Sed. B to F: The expression levels of MHC α/β, β1-AR, Grk5, β2-AR, and 
Chrm2 showed no obvious changes. G to I: In calcium handling related 
genes, there were no obvious differences in the expressions of RyR2 and 
PLN, while Atp2a2 (SERCA2a) was significantly lower in MI-Sed than 
Sham and was restored in MI-Ex and MI-βb. (n=8/group). *P<0.05, vs. 
Sham; #P<0.05, vs. MI-Sed. 
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3.4.2 The protein expressions of calcium handling related molecules 
 
Next, we assessed the protein expressions of calcium handling related 
molecules. The ratio of phosphorylated RyR2 at Serine 2814 to total RyR2 
was significantly increased in MI-Sed compared with Sham and decreased 
in MI-Ex and MI-βb groups (Fig. 12A). By contrast, there were no 
differences in the ratio of phosphorylated RyR2 at Serine 2808 to total 
RyR2 between the MI groups. The expression of SERCA2a was 
significantly decreased in MI-Sed compared with Sham, and restored in 
MI-Ex and MI-βb groups (Fig. 12B). The expression of p-PLN/PLN 
showed slightly increased in MI- Ex, but the difference was not significant 
between all groups (Fig. 12C). It has been reported that reduced p-TNI 
could be an indicator of increased Ca2+ sensitivity in post-MI (van der 
Velden et al. 2004). In our study, although both the expressions of TNI and 
p-TNI were decreased in MI groups compared with Sham, the ratio of p-
TNI to TNI showed no obvious difference (Fig. 12D).  
We further determined the protein activity of the upstream kinases that 
regulate the amplitude and kinetics of calcium cycling. Exercise and β-
blocker treatment suppressed CaMKII hyperphosphorylation without 
alteration of expression levels of oxidized-CaMKII and total CaMKII (Fig. 
12E). By contrast, there were no significant differences in PKA and 
phosphorylated PKA (T197) expressions (Fig. 12F).  
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Figure 12. Western blotting analysis.  
A: The phosphorylated RyR2 at Serine 2814 site was significantly 
increased in MI-Sed compared with Sham and was decreased in MI-Ex and 
MI-βb. There was no change in the expression of phosphorylated RyR2 at 
Serine 2808 site or total RyR2. B: The protein expression of SERCA2a in 
MI-Sed was significantly decreased compared with Sham and was 
recovered in MI-Ex and MI-βb. C: The expression of p-PLN/PLN showed 
slightly increased in MI- Ex, but the differences were not significant 
between all groups. D: Although both the expressions of TNI and p-TNI 
were decreased in MI groups compared with Sham, the ratio of p-TNI to 
TNI showed no obvious difference. E: The expression level of p-CaMKII 
was obviously increased in MI-Sed, and it was decreased in MI-Ex and MI-
βb without significant alterations of oxidized-CaMKII and total CaMKII 
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expressions. F: There were no significant differences in PKA and 
phosphorylated PKA (T197) expressions between all groups. (n=6/group). 
*P<0.05, vs. Sham; #P<0.05, vs. MI-Sed.  
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3.5 Exercise decreases miR-1 expression and improves PP2A 
expression. 
 
The miRNAs are a class of small single-stranded and highly conserved 
non-coding RNAs, which post-transcriptionally regulate gene expression 
(Bartel 2009). In the miRNA family, miR-1and miR-133a were the first 
described striated muscle-specific miRNAs and are closely linked to 
cardiac disorders such as MI, heart failure, and arrhythmia (Belevych et al. 
2011; Matkovich et al. 2009). Therefore, we evaluated the expression of 
miR-1 and miR-133a. We found that miR-1 expression was significantly 
elevated in MI-Sed, but restored by exercise and β-blocker treatment (Fig. 
13A), while there was no significant difference in miR-133a expression 
(Fig. 13B).   
Protein phosphorylation is regulated by the balance of kinase and 
phosphatase activities. PP1 and PP2A are major serine–threonine 
phosphatases involved in the dephosphorylation of specific substrates 
(Terentyev et al. 2009). The expression of the PP2A regulatory subunit 
B56α (F-10) was significantly decreased in MI-Sed, and restored in MI-Ex 
and MI-βb groups (Fig. 13C). However, there were no differences in PP1 
protein expression between the groups (Fig. 13D). 
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Figure 13. Exercise decreases miR-1 expression and improves PP2A 
expression. 
A: The expression of microRNA-1 (miR-1) in the LV was elevated in MI-
Sed and reduced by exercise and β-blocker treatment. B: There was no 
difference in the expression of miR-133a between the groups. (n=5/group). 
C: There was no difference in expression of protein phosphatase 1 (PP1), 
while PP2A-B56-α (F-10) expression was significantly decreased in MI-
Sed compared to that in Sham and reversed in MI-Ex and MI-βb (D). 
(n=6/group) *P<0.05, vs. Sham; #P<0.05, vs. MI-Sed. 
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Chapter 4 Discussion 
 
In the present study, we found that chronic intensive exercise training 
improved the imbalance of sympathetic and parasympathetic activities, 
reduced the incidence of PVC and VT, and restored calcium handling in MI 
mice, despite no obvious alterations in cardiac structure or function. Thus, 
exercise training in subacute to chronic phase of MI did not increase the 
risk of malignant arrhythmias, but rather restores autonomic function and 
cardiac electrical stability.  
Although both exercise and treatment with β-blockers did not alter MI 
area and cardiac systolic function, we found that exercise training 
significantly improved peak VO2. This finding is consistent with the 
previous observation that exercise has a better effect on cardiopulmonary 
function and exercise capacity (Jaureguizar et al. 2016). We also found that 
6-week exercise restored autonomic imbalance showed by LF/HF and 
decreased spontaneous ventricular arrhythmias. Autonomic nervous 
remodeling occurs after MI, which is critical for the incidence of 
tachyarrhythmias and sudden cardiac death (Shen et al. 2014). Billman GE 
and colleagues reported that β2-adrenergic stimulation was relatively 
activated, and its receptor antagonist could suppress the incidence of VF in 
canine MI model through restoring intracellular Ca2+ transients (Billman et 
al. 1997). They also reported that endurance exercise training normalized 
repolarization and calcium-handling abnormalities, prevented ventricular 
fibrillation (VF) in ischemia-induced canine model of sudden cardiac death 
(Billman 2009; Bonilla et al. 2012). Therefore, autonomic imbalance and 
calcium handling abnormality play critical roles in the occurrence of 
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ventricular tachyarrhythmias after MI, and exercise training could 
ameliorate such pathological conditions. In the failing heart, RyR2 
hyperphosphorylation at serine 2814 site by CaMKII increases diastolic 
calcium leak, leading to delayed after-depolarization and triggering of VT 
(Gonano et al. 2011; Lanner et al. 2010). We showed that phosphorylated 
CaMKII and Ser2814-phosphorylated RyR2 were significantly increased in 
MI-Sed compared with Sham, which were suppressed by exercise. Exercise 
training was previously reported to reduce RyR2-induced calcium release 
from the SR and reduce VT in diabetic mice after MI (Rolim et al. 2015). 
Thus, inhibition of CaMKII dependent-RyR2 hyperphosphorylation by 
chronic exercise training may be a key mechanism underlying the 
suppression of ventricular arrhythmias in heart failure after MI. 
In the present study, bisoprolol treatment also restored the 
hyperphosphorylation of CaMKII and RyR2 at Ser2814, as well as the 
expression of SERCA2a, suggesting an improvement in calcium handling, 
as for exercise training. Although β-blocker treatment did not improve 
cardiopulmonary function and exercise capacity, it showed a more 
powerful effect on improving HRV (prolonging R-R interval and 
increasing SDNN) and reducing ventricular arrhythmias. Thus, the 
combination of these two therapies may lead to a better integrative 
outcome. Vanzelli et al. reported that combined aerobic exercise training 
and carvedilol treatment had a positive impact on heart failure using a 
genetic model of sympathetic hyperactivity-induced heart failure, albeit via 
a different mechanism (Vanzelli et al. 2013). The beneficial effects of 
combined therapies, including improved cardiac calcium handling, are 
mainly related to the effects of exercise training and the reduced 
myocardial oxidative stress and reversed ventricular remodeling associated 
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with carvedilol therapy (Vanzelli et al. 2013). Our contrasting findings may 
be attributed to differences in the model, pharmacological agent, and study 
protocol. 
There is now strong evidence for an important role of miRNAs in 
regulating cardiac function and structural changes during normal cardiac 
development, as well as in pathological conditions such as heart failure 
(Bartel 2009; Olson 2014; Pinti et al. 2017). Of more than 1000 miRNAs, 
miR-1 and miR-133 are recognized as muscle-specific miRNAs and play 
an important role in the pathogenesis of heart failure and arrhythmia (Li et 
al. 2015). However, the behavior of miRNAs in heart failure remains 
controversial. While some studies have reported a reduction in miR-1 
expression in hypertrophy and heart failure (Diniz et al. 2017; Ikeda et al. 
2009; Li et al. 2015), others have reported an increase (Long et al. 2012; 
Matkovich et al. 2009). In the present study, miR-1 expression was 
upregulated, while miR-133 was unchanged, in MI groups compared with 
Sham. The differences in cardiac miR-1 and miR-133 expression may 
depend on the stages and etiology of heart failure. We showed that elevated 
miR-1 expression in MI was significantly restored by chronic exercise 
training and β-blocker treatment, which is consistent with a previous study 
showing that β-adrenergic antagonists can downregulate miR-1 (Lu et al. 
2009). Moreover, some studies reported that exercise training restored 
cardiac miR-1 and regulating calcium handling (Melo et al. 2015; Silveira 
et al. 2017). Terentyev et al. also reported that miR-1-overexpressing 
cardiomyocytes exhibited spontaneous arrhythmogenic oscillations of 
intracellular calcium, via a selective increase in phosphorylation of the L-
type calcium channel and RyR2 at Serine 2814 (CaMKII-dependent 
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phosphorylation site), and downstream regulation of PP2A activity 
(Terentyev et al. 2009).  
PP2A is the target molecule of miR-1(Terentyev et al. 2009), and the 
authors reported that expression of miR-1 and miR-133 were significantly 
increased in heart failure, while expression of PP2A catalytic and 
regulatory subunits (putative targets of miR-133 and miR-1) were 
decreased (Belevych et al. 2011). Moreover, the decreased PP2A activity 
observed in heart failure was accompanied by enhanced CaMKII-mediated 
phosphorylation of RyR2 at Ser-2814, and increased frequency of diastolic 
calcium waves and after-depolarizations, in heart failure rats compared 
with controls (Terentyev et al. 2009). Taken together, these findings 
suggest that the antiarrhythmic effects of chronic exercise or β-blocker 
treatment are, at least in part, related to regulation of miR-1 expression, and 
downstream phosphatase activity of calcium handling-related molecules, in 
cardiomyocytes.  
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Figure 14. The effect of exercise in calcium modulating.  
In failing heart, RyR2 hyperphosphorylation at serine 2814 site by CaMKII 
increases diastolic Ca2+ leak, leading to delayed after depolarization and 
triggering ventricular tachyarrhythmias. Exercise training restored the 
elevated expression of miR-1 in MI. As the targeting subunit of miR-1, 
PP2A, which committed to dephosphorylation of CaMKII and RyR2, was 
recovered by exercise. Therefore, it is suggested that inhibition of CaMKII 
dependent-RyR2 hyperphosphorylation by chronic exercise training 
reduced the abnormal Ca2+ leak and is a main mechanism of suppression of 
ventricular arrhythmias in heart failure after MI.  
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Chapter 5 Limitations 
 
There are several limitations in this study. Although we analyzed the 
protein expression levels of calcium handling molecules, we didn’t 
measure intracellular calcium content. This is recognized as a major 
limitation in our study. In addition, the valid sample number in HRV 
analysis was only 4, and although we showed SDNN value as a major 
parameter of HRV, the others such as PNN50 were not obtained. We 
decided to keep 6-week intervention to obtain enough effectiveness 
according to the previous researches (Rolim et al. 2015; Speaker et al. 
2014). Because structural remodeling process might be almost completed 
within 1 month after MI or even shorter, we supposed longer intervention 
would not have yield different results. However, we cannot exclude the 
possibilities that longer or shorter period of intervention or start period of 
intervention would yield different results in this study, and further research 
will be recommended.    
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Chapter 6 Conclusion 
 
 
In summary, we conclude that continuous intensive exercise training 
can suppress ventricular arrhythmias in subacute to chronic phase of MI 
through restoring autonomic imbalance and impaired calcium handling, 
similarly to that for β-blockers. It is suggested that the antiarrhythmic 
effects of chronic intensive exercise or β-blocker treatment are, at least in 
part, attributed to regulations of miR-1-mediated PP2A activity and its 
downstream targets, hyperphosphorylated CaMKII-RyR2, in MI. Thus, 
exercise may be a safe and effective therapy for improving outcome in 
heart failure patients after MI. 
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